The FDA is approving an Eli Lilly developed combination therapy to treat COVID-19 patients. The Indianapolis-headquartered pharmaceutical company got emergency use authorization from the FDA Tuesday. Lilly’s treatment combination therapy treats patients with a mild to moderate case of the coronavirus. Eli Lilly plans to make over 250-thousand doses of the single injection therapy through March.
